Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 21 Sponsors

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber: Senate
Introduced: Jan 28, 2025
Last action: Apr 28, 2025 — Comp. became Pub. Ch. 295
Session: 114
Momentum: 36 · Low

PASSAGE PROBABILITY

25.9% Uncertain

Why this number

Stage base In Committee — base rate 51%, measured from TN's completed sessions
Momentum -3 36/100 from the pace of recorded action
Time since last action -22 534 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.